Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

860
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
860
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

355
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
355
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

109
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
109

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hepatocellular Carcinoma Precursor Lesions: From Pathological Basis to Risk Stratification and Precision Intervention.

Journal of hepatocellular carcinoma·2026
Same author

Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions.

MedComm·2026
Same author

Radix Rehmanniae Praeparata Extract Enhances Liver Regeneration Through AMPK-Driven Metabolic Reprogramming.

Nutrients·2025
Same author

Temporal-spatially metabolic reprogramming rewires the landscape of H3K27 acetylation to enable the initiation of liver regeneration.

Science bulletin·2025
Same author

Decoding the role of immune T cells: A new territory for improvement of metabolic-associated fatty liver disease.

iMeta·2024
Same author

Ferulic acid ameliorates acetaminophen-induced acute liver injury by promoting AMPK-mediated protective autophagy.

IUBMB life·2022

Related Experiment Video

Updated: May 13, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

692

Special correlation between diet and MASLD: positive or negative?

Jia Liu1, Changmeng Li2, Yun Yang1

  • 1School of Life Sciences, Beijing University of Chinese Medicine, Beijing, 100029, China.

Cell & Bioscience
|April 12, 2025
PubMed
Summary

Dietary interventions are crucial for managing metabolic dysfunction-associated steatotic liver disease (MASLD). Understanding how diet impacts liver health and the gut-liver axis can reveal new therapeutic strategies for MASLD.

Keywords:
Curative strategyDietary modelsDietary therapyHepato-intestinal axisMASLDPathological mechanism

More Related Videos

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

5.9K

Related Experiment Videos

Last Updated: May 13, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
07:03

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss

Published on: July 19, 2024

692
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

15.8K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

5.9K

Area of Science:

  • Hepatology
  • Metabolic Diseases
  • Nutritional Science

Background:

  • Metabolic dysfunction-associated steatotic liver disease (MASLD) is a chronic liver condition linked to cardiometabolic risk factors.
  • Pathogenesis involves lipid disorders, insulin resistance, inflammation, and the gut-liver axis.
  • Diet plays a dual role, both exacerbating and potentially treating MASLD.

Purpose of the Study:

  • To explore the role of diet in MASLD pathogenesis and progression.
  • To summarize the therapeutic effects of dietary optimization in MASLD.
  • To elucidate how specific dietary components regulate the gut-liver axis and lipid metabolism.

Main Methods:

  • Utilizing dietary induction models in animal studies to investigate MASLD mechanisms.
  • Analyzing the impact of high-lipid diets on liver fat accumulation, oxidative stress, and inflammation.
  • Reviewing studies on dietary interventions and specific nutrients for MASLD treatment.

Main Results:

  • High-lipid diets worsen MASLD by increasing fat, oxidative stress, and inflammation.
  • Dietary optimization shows therapeutic potential in MASLD.
  • Specific dietary components can modulate the gut-liver axis and lipid metabolism.

Conclusions:

  • Animal models provide key insights into dietary therapy for MASLD.
  • Dietary strategies can target lipid metabolism and gut-liver signaling pathways.
  • Probiotics show promise in hepatoenteric regulation for MASLD management.